Asacol and Zometa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Asacol (mesalamine) and Zometa (zoledronic acid). Common drug interactions include periodontitis among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Asacol and Zometa. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Asacol?

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 20,618 Asacol users. Check the latest studies of Asacol.

What is Zometa?

Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

96 people who take Asacol and Zometa together, and have interactions are studied.

Asacol and Zometa drug interactions.

What are the common drug interactions of Asacol and Zometa, by gender? *:

female:

  1. Periodontitis (inflammation of the tissue around the teeth)
  2. Pleural effusion (water on the lungs)
  3. Anaemia (lack of blood)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Osteoporosis (bones weak and more likely to break)
  6. Osteolysis (dissolution of bone)
  7. Fatigue (feeling of tiredness)
  8. Gingivitis (inflammation of gums)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Swelling face

male:

  1. Anxiety
  2. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  3. Arteriosclerosis (thickening and hardening of arteries)
  4. Bone loss
  5. Decreased interest
  6. Exposed bone in jaw
  7. Fear
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Osteoporosis (bones weak and more likely to break)
  10. Patella fracture

What are the common drug interactions of Asacol and Zometa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cellulitis (infection under the skin)
  2. Lung infection
  3. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  4. Stomatitis (inflammation of mucous membrane of mouth)

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  3. Activities of daily living impaired
  4. Adrenal disorder
  5. Anxiety
  6. Atelectasis (partial or complete collapse of the lung)
  7. Bone loss
  8. Cardiac failure congestive
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)

50-59:

  1. Spinal osteoarthritis (joint cartilage loss in spine)
  2. Swelling
  3. Osteolysis (dissolution of bone)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Diarrhoea
  6. Aptyalism (deficiency or absence of saliva)
  7. Bone disorder
  8. Bone erosion
  9. Exostosis (formation of new bone on the surface of a bone)
  10. Generalised oedema (swelling all over the body)

60+:

  1. Osteomyelitis (infection of bone)
  2. Arteriosclerosis (thickening and hardening of arteries)
  3. Hypertension (high blood pressure)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Hypotension (abnormally low blood pressure)
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Joint effusion (presence of extra fluid in joint covering)
  8. Osteitis (a general term for inflammation of bone)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Osteoporosis (bones weak and more likely to break)

What are the existing conditions these people have? *

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 34 people, 35.42%
  2. Osteoporosis (bones weak and more likely to break): 34 people, 35.42%
  3. Osteopenia (a condition where bone mineral density is lower than normal): 18 people, 18.75%
  4. Thrombocytopenia (decrease of platelets in blood): 11 people, 11.46%
  5. Metastases To Bone (cancer spreads to bone): 11 people, 11.46%
  6. Pain: 10 people, 10.42%
  7. Colitis (inflammation of colon): 8 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Asacol and Zometa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Asacol and Zometa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Asacol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zometa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Asacol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zometa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and zoledronic acid (the active ingredients of Asacol and Zometa, respectively), and Asacol and Zometa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: